recurrence of breast cancer after lumpectomy

Release time ：Nov-10,2024

The recurrence of breast cancer after lumpectomy is a possibility, but not a certainty. Multiple factors contribute to the risk of recurrence, including the tumor's biological features, the quality of the surgery performed, the receipt of adjuvant therapies, and individual patient characteristics.

The biological nature of the tumor plays a significant role in determining the likelihood of recurrence. For instance, breast cancers that are hormone receptor-positive tend to have a higher risk of recurrence compared to triple-negative breast cancers. The quality of the surgery is also paramount; if the surgical margins are positive (indicating the presence of cancer cells at the edges of the removed tissue), the risk of recurrence is likely to increase. Additionally, the receipt of adjuvant treatments such as radiation, chemotherapy, or endocrine therapy can influence the risk of recurrence. Lastly, patient-specific factors like age and genetic predispositions may also impact the risk of recurrence.

Consequently, for breast cancer patients post-lumpectomy, regular follow-ups and examinations are essential. Should any signs of recurrence emerge, it is imperative to seek medical attention without delay to initiate appropriate treatment as early as possible. Moreover, patients should adhere to their physicians' recommendations and actively engage in adjuvant therapies to mitigate the risk of recurrence.